Helius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest Down 65.6% in February

Helius Medical Technologies, Inc. (NASDAQ:HSDT) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 19,100 shares, a decrease of 65.6% from the February 13th total of 55,500 shares. Approximately 0.5% of the company’s stock are sold short. Based on an average trading volume of 4,430,000 shares, the days-to-cover ratio is presently 0.0 days.

Hedge Funds Weigh In On Helius Medical Technologies

A hedge fund recently bought a new stake in Helius Medical Technologies stock. Virtu Financial LLC acquired a new stake in Helius Medical Technologies, Inc. (NASDAQ:HSDT) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 46,510 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned about 1.25% of Helius Medical Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 18.63% of the company’s stock.

Helius Medical Technologies Stock Down 2.6 %

NASDAQ:HSDT traded down $0.01 during mid-day trading on Thursday, reaching $0.41. The company’s stock had a trading volume of 200,949 shares, compared to its average volume of 3,261,879. Helius Medical Technologies has a 1 year low of $0.37 and a 1 year high of $7.19. The stock has a fifty day moving average of $0.61 and a 200-day moving average of $0.62. The firm has a market capitalization of $1.54 million, a PE ratio of -0.07 and a beta of 1.62.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.